Legend Biotech Corp share price logo

Legend Biotech Corp

NASDAQ: LEGN

Mid Cap

$34.86

+1.37

(+4.09%)

as on

Legend Biotech Corp Stock Performance

as on June 11, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $32.70
    $35.09
    downward going graph

    6.20%

    Downside

    0.66%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $16.24
    $45.30
    downward going graph

    53.41%

    Downside

    29.94%

    Upside

    downward going graph

Legend Biotech Corp share price movements today

Previous Close
$33.49
Open
$32.70
Volume
1.3M
Day's Low - High
$32.70 - $35.09
52 Week Low - High
$16.24 - $45.30

Legend Biotech Corp Historical Returns

1 Month Return
+ 19.1 %
3 Month Return
+ 71.22 %
1 Year Return
-11.03 %
3 Year Return
-50.47 %
5 Year Return
-18.5 %

Legend Biotech Corp Stock Fundamentals & Key Indicators

Check Legend Biotech Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.1B

EPS (TTM)

0.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

-21.96%

Return On Equity TTM

-25.19%

Legend Biotech Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Legend Biotech Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$6.1B-18.5%NA-21.96%NA
BUY$39.0B82.34%73.5912.55%NA
BUY$112.4B105.64%26.3235.51%NA
BUY$64.1B15.81%14.9329.65%0.5599999999999999%

Stock Returns calculator for Legend Biotech Corp Stock including INR - Dollar returns

The Legend Biotech Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Legend Biotech Corp investment value today

Current value as on today

₹1,06,001

Returns

₹6,001

(+6%)

Returns from Legend Biotech Corp Stock

-₹7,386 (-7.39%)

Dollar Impact

₹13,386 (+13.39%)

Analyst Recommendation on Legend Biotech Corp Stock

Based on 27 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Legend Biotech Corp. Average target price of $57.59

Legend Biotech Corp Share Price Target

Get share price movements and forecasts by analysts on Legend Biotech Corp.

What analysts predicted

39.47%UPSIDE

Target Price

$57.59

Current Price

$34.86

Analyzed by

27 Analysts

Target

$57.59

Legend Biotech Corp target price $57.59, a slight upside of 39.47% compared to current price of $34.86. According to 27 analysts rating.

Indian Investors' Interest in Legend Biotech Corp Stock

Search interest for Legend Biotech Corp Stock has increased by 87% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:87% versus previous 30 day period

Legend Biotech Corp Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
79
93
186
160
186
195
255
272
306
305
Gross Profit
47
39
136
104
112
123
157
157
182
129
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-144
-59
-18
-125
26
-100
-125
-39
-30
-54
Net Profit Margin
-182.24%
-63.62%
-9.76%
-78.23%
14.09%
-51.74%
-49.16%
-14.57%
-10.06%
-17.80%

Legend Biotech Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
23
49
61
75
68
117
285
627
1,028
Gross Profit
23
49
61
75
68
51
140
392
620
Operating Income
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
9
-2
-101
-266
-403
-446
-518
-177
-296
Net Profit Margin
39.69%
-5.67%
-164.39%
-355.16%
-586.38%
-381.48%
-181.75%
-28.22%
-28.85%

Global Institutional Holdings in Legend Biotech Corp

Funds
Holdings
Point72 Asset Management, L.P.
2.09%
UBS Group AG
0.55%
Acadian Asset Management LLC
0.82%
Johnson & Johnson
0.44%
Goldman Sachs Group Inc
0.51%

Legend Biotech Corp News & Key Events

  • img

    Today's Timeline - 12 May

    Tue, 04:30 PM

    -

    Legend Biotech reports significant CARVYKTI sales growth and improved financial metrics for Q1 2026.

    Tue, 05:36 PM

    -

    Q1 2026 revenue surged 56% YoY, driven by CARVYKTI sales, with profitability anticipated in 2026.

    Tue, 06:37 PM

    -

    Q1 2026 earnings call highlights strong CARVYKTI sales growth and expectations for profitability in 2026.

  • img

    Today's Timeline - 12 May

    Tue, 06:46 PM

    -

    CARVYKTI sales surged 62% YoY in Q1 2026, with margin recovery expected in Q2.

    Tue, 06:50 PM

    -

    Legend Biotech reports Q1 2026 revenue of $305.1 million, net loss of $54.3 million, and improved loss per share.

Insights on Legend Biotech Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LEGN stock has moved up by 30.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Legend Biotech Corporation American Depositary Shares has experienced a drawdown of -50.5%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 33.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.8% return, outperforming this stock by 27.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -30.81M → -54.3M (in $), with an average decrease of 76.2% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 306.37M → 305.1M (in $), with an average decrease of 0.4% per quarter

About Legend Biotech Corp

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
OrganisationLegend Biotech Corp
Headquarters2101 Cottontail Lane, Somerset, NJ, United States, 08873
IndustryBiotechnology
CEODr. Ying Huang Ph.D.
E-voting on sharesClick here to vote

Key Management of Legend Biotech Corp

Name

Title

Dr. Ying Huang Ph.D.

CEO & Director

Mr. James Pepin J.D.

General Counsel

Dr. Guowei Fang Ph.D.

President of Research & Development

Mr. Alan S. Bash

President of CARVYKTI®

Surabhi Verma

Manager of Investor Relations & Corporate Communications

Mr. Carlos Santos

Chief Financial Officer

Ms. Jessie Yeung M.B.A.

Vice President of Finance, Investor & Public Relations

Ms. Ananda Elizabeth Martin Esq., J.D.

Global Compliance Officer

Mr. Birk Vanderweeen

Senior Vice President of Global Manufacturing & Supply

Ms. Joanne Choi

Senior Manager of Investor Relations

FAQs

What is Legend Biotech Corp share price today?

Legend Biotech Corp share price today is $34.86 as on at the close of the market. Legend Biotech Corp share today touched a day high of $35.09 and a low of $32.7.

What is the 52 week high and 52 week low for Legend Biotech Corp share?

Legend Biotech Corp share touched a 52 week high of $45.3 on and a 52 week low of $16.24 on . Legend Biotech Corp stock price today i.e. is closed at $34.86,which is 23.04% down from its 52 week high and 114.66% up from its 52 week low.

What is Legend Biotech Corp's market capitalisation today?

Legend Biotech Corp market capitalisation is $0.01T as on .

How to invest in Legend Biotech Corp Stock (LEGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Legend Biotech Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Legend Biotech Corp Shares that will get you 0.0430 shares as per Legend Biotech Corp share price of $34.86 per share as on June 11, 2026 at 8:45 am IST.

What is the minimum amount required to buy Legend Biotech Corp Stock (LEGN) from India?

Indian investors can start investing in Legend Biotech Corp (LEGN) shares with as little as ₹95.34 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.40 in Legend Biotech Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Legend Biotech Corp share’s latest price of $34.86 as on June 11, 2026 at 8:45 am IST, you will get 0.2869 shares of Legend Biotech Corp. Learn more about fractional shares .

What are the returns that Legend Biotech Corp has given to Indian investors in the last 5 years?

Legend Biotech Corp stock has given -18.5% share price returns and 21.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?